Oklo, Nano Nuclear, Centrus, NuScale Surge as White House Space Nuclear Mandate Electrifies the Sector

A White House memorandum targeting orbital nuclear reactors by 2028 and lunar reactors by 2030 sparked a broad rally across nuclear stocks, with Oklo jumping 8% intraday before pulling back to $64. Oklo is up 32% over the past week, Centrus Energy rose 2% to around $202, and NuScale traded near $11.50 as investors reassessed the sector’s long-term addressable market. The policy also highlights commercialization potential for Nano Nuclear and strengthens the case for domestic fuel and SMR developers.

Analysis

The market is starting to reprice these names as a policy stack, not four separate equities. The key second-order effect is that a space-reactor mandate does not just lift end-product developers; it pulls forward demand for enriched fuel, qualification testing, thermal management, radiation-hard components, and government procurement capacity. That shifts relative value toward the least binary balance sheets and the deepest regulatory moats, which is why LEU and SMR should have more durable multiple support than the pre-revenue names if the theme persists beyond a few sessions.

Near term, the move is likely being driven more by positioning than by fundamentals. These stocks have become crowded thematic expressions, so the first leg higher can overshoot on headline flow, but the next catalyst must be concrete contract allocation, not just rhetoric. If no agency budget line or procurement timetable emerges within 2-6 weeks, the group is vulnerable to mean reversion as traders rotate out of event-driven beta and back into cleaner cash-flow stories.

The most interesting contrarian read is that the market may be overestimating how quickly space deployment translates into revenue. Nuclear in orbit is an engineering, safety, and launch-integration problem first, a policy story second; the path from directive to purchase orders can be long, and that gap is where these names can re-rate downward. The better long is the supplier with existing production and backlog, while the weakest risk/reward remains in the highest-duration developers where a failed milestone can erase multiple quarters of sentiment gains.

Key Decisions for Investors

• Overweight LEU vs the rest of the basket over the next 1-3 months; it has the best mix of policy optionality and current cash-flow support. Use dips below recent breakout levels to add, with a stop if the theme cools and LEU gives back the prior week’s gain.
• Initiate a pair trade: long LEU / short OKLO for 4-8 weeks. The thesis is that policy enthusiasm will eventually favor the company with commercial relevance and backlog over the most sentiment-driven pre-revenue name; target 15-20% relative outperformance if the market starts demanding execution.
• Buy SMR calls or a call spread out 2-4 months rather than common stock. The regulatory approval gives it a cleaner path to a rerating, but the stock can still be violently bid-only; structure the trade to capture upside while limiting downside if the headline fades.
• Avoid chasing NNE at current levels; if you want exposure, wait for a pullback after the first contract-related headline fails to materialize. This is the highest-beta name in the set and likely the first to retrace if the market shifts from narrative to implementation.
• For tactical traders, consider a short-dated basket call spread on OKLO/NNE only if you expect another procurement headline within days; otherwise the better expression is selling volatility after the initial spike, because the event risk is front-loaded and follow-through is uncertain.